Antimigraine medication use and associated health care costs in employed patients

Journal of Headache and Pain

Volumn 13, Issue 2, 2012, Pages 121-127

  Wu, Jun ^a   Hughes, Mary D ^b   Hudson, Matthew F ^b   Wagner, Peggy J ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

Antimigraine medication use; Employed patients; Health care costs; Migraine

Indexed keywords

ALMOTRIPTAN; ALPRAZOLAM; AMITRIPTYLINE; ANTIMIGRAINE AGENT; CAFFEINE; CHLORDIAZEPOXIDE; CITALOPRAM; CLOMIPRAMINE; CLORAZEPATE DIPOTASSIUM; DESIPRAMINE; DESVENLAFAXINE; DIAZEPAM; DICHLORALPHENAZONE; DIHYDROERGOTAMINE MESILATE; DOXEPIN; DULOXETINE; ELETRIPTAN; ERGOTAMINE; ESCITALOPRAM; FLUOXETINE; FROVATRIPTAN; ISOMETHEPTENE; LORAZEPAM; MIRTAZAPINE; NAPROXEN PLUS SUMATRIPTAN; NARATRIPTAN; PARACETAMOL; RIZATRIPTAN; UNINDEXED DRUG; ZOLMITRIPTAN;

ARTICLE; DEPRESSION; EMPLOYMENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; MIGRAINE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY;

ADULT; ANALGESICS; DRUG UTILIZATION REVIEW; EFFICIENCY; EMPLOYMENT; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIGRAINE DISORDERS;

EID: 84859618017     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-011-0405-6     Document Type: Article

References (29)

1. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF (2002) Migraine in the United States: Epidemiology and patterns of health care use. Neurology 58:885-894 (Pubitemid 34242063)
2. Lipton RB, Stewart WF, Diamond S, Diamonds ML, Reed M (2001) Prevalence and burden of migraine in the United States: Data from the american migraine study II. Headache 41:646-657 (Pubitemid 32777747)
3. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB (2007) Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study. Headache 47:355-363 (Pubitemid 46426410)
4. Stang PE, Osterhaus JT (1993) Impact of migraine in the United States: Data from the national health interview survey. Headache 33:29-35 (Pubitemid 23057823)
5. Lipton RB, Stewart WF, von Korff M (1997) Burden of migraine: Societal costs and therapeutic opportunities. Neurology 48:S4-S9 (Pubitemid 27120080)
6. Landy SH, Runken MC, Bell CF, Higbie RL, Haskins LS (2011) Assessing the impact of migraine onset on work productivity. J Occup Environ Med 53:74-81
7. Manack AN, Buse DC, Lipton RB (2011) Chronic migraine: Epidemiology and disease burden. Curr Pain Headache Rep 15:70-78
8. Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression: A populationbased case-control study. Neurology 55:629-635
9. Smith TR, Nicholson RA, Banks JW (2010) Migraine education improves quality of life in a primary care setting. Headache 50:600-612
10. Mennini FS, Gitto L, Martelletti P (2008) Improving care through health economics analyses: Cost of illness and headache. J Headache Pain 9:199-206
11. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML (1999) Burden of migraine in the United States: Disability and economic costs. Arch Intern Med 159:813-818 (Pubitemid 29200307)
12. Goldberg LD (2005) The cost of migraine and its treatment. Am J Manag Care 11:S62-S67
13. Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology 71:559-566
14. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS (2005) Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43:521-530 (Pubitemid 40847288)
15. Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R (2011) Medical utilization and costs associated with statin adherence in medicaid enrollees with type 2 diabetes. Ann Pharmacother 45:342-349
16. Aubert RE, Yao J, Xia F, Garavaglia SB (2010) Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care 16:459-466
17. Simpson RJ, Signorovitch J, Birnbaum H, Ivanova J, Connolly C, Kidolezi Y, Kuznik A (2009) Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population. Mayo Clin Proc 84:1065-1072
18. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT (2003) Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study. Clin Ther 25:2958-2971 (Pubitemid 37510603)
19. Fishman P, Black L (1999) Indirect costs of migraine in a managed care population. Cephalalgia 19:50-57 (discussion 1)
20. Lofland JH, Frick KD (2006) Workplace absenteeism and aspects of access to health care for individuals with migraine headache. Headache 46:563-576
21. Stewart WF, Wood GC, Razzaghi H, Reed ML, Lipton RB (2008) Work impact of migraine headaches. J Occup Environ Med 50:736-745
22. Louter MA, Veen G, Ferrari MD, Zitman FG, Terwindt GM (2010) Migraine and depression should be treated concurrently. Ned Tijdschr Geneeskd 154:A1044
23. Frediani F, Villani V (2007) Migraine and depression. Neurol Sci 28(Suppl 2):S161-S165 (Pubitemid 46813647)
24. Gautam S, Singh S (2008) Predicting overall and impactable future cost with the D2Hawkeye risk modeling system. http:\\www. d2hawkeyeservices.com. Accessed 12 November 2010
25. Clouse JC, Osterhaus JT (1994) Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother 28:659-664 (Pubitemid 24141476)
26. McCaig LF, Burt CW (2004) National hospital ambulatory medical care survey: 2002 emergency department summary. Adv Data 340:1-34
27. McCaig LF, Nawar EW (2006) National hospital ambulatory medical care survey: 2004 emergency department summary. Adv Data 372:1-29
28. Wertz DA, Quimbo RM, Yaldo AZ, Rupnow MF (2009) Resource utilization impact of topiramate for migraine prevention in the managed-care setting. Curr Med Res Opin 25:499-503
29. Sheftell FD, Atlas SJ (2002) Migraine and psychiatric comorbidity: From theory and hypotheses to clinical application. Headache 42:934-944 (Pubitemid 35285388)